A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivity-Reference-Cited by-同舟云学术

A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivity

Published:2005-05-11 Issue:13 Volume:14 Page:1745-1751
ISSN:1460-2083
Container-title:Human Molecular Genetics
language:en
Short-container-title:

Author:

Yuan Hsiang-Yu,Chen Jin-Jer,Lee M.T. Michael,Wung Ju-Chieh,Chen Ying-Fu,Charng Min-Ji,Lu Ming-Jen,Hung Chi-Ren,Wei Chun-Yu,Chen Chien-Hsiun,Wu Jer-Yuarn,Chen Yuan-Tsong

Publisher

Oxford University Press (OUP)

Subject

Genetics(clinical),Genetics,Molecular Biology,General Medicine

Link

http://academic.oup.com/hmg/article-pdf/14/13/1745/1717596/ddi180.pdf

Reference31 articles.

1. Hirsh, J. (1992) Antithrombotic therapy in deep vein thrombosis and pulmonary embolism. Am. Heart J., 123, 1115–1122.

2. Laupacis, A., Albers, G., Dalen, J., Dunn, M., Feinberg, W. and Jacobson, A. (1995) Antithrombotic therapy in atrial fibrillation. Chest, 108, 352S–359S.

3. Stein, P.D., Alpert, J.S., Copeland, J., Dalen, J.E., Goldman, S. and Turpie, A.G. (1995) Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest, 108, 371S–379S.

4. Hirsh, J., Dalen, J., Anderson, D.R., Poller, L., Bussey, H., Ansell, J. and Deykin, D. (2001) Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest, 119, 8S–21S.

5. Loebstein, R., Yonath, H., Peleg, D., Almog, S., Rotenberg, M., Lubetsky, A., Roitelman, J., Harats, D., Halkin, H. and Ezra, D. (2001) Interindividual variability in sensitivity to warfarin—nature or nurture? Clin. Pharmacol. Ther., 70, 159–164.

Cited by 416 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hereditary Thrombophilia: A Case of Subacute Pulmonary Embolism in a 68-Year-Old Female with a Mutation in the PROC Gene;Seminars in Thrombosis and Hemostasis;2024-08-16

2. Construction of warfarin population pharmacokinetics and pharmacodynamics model in Han population based on Bayesian method;Scientific Reports;2024-06-27

3. A Chinese patient with cardiogenic stroke and warfarin resistance: A case report;2024-04-09

4. Association between CYP2C9 and VKORC1 genetic polymorphisms and efficacy and safety of warfarin in Chinese patients;Pharmacogenetics and Genomics;2024-03-07

5. Being precise with anticoagulation to reduce adverse drug reactions: are we there yet?;The Pharmacogenomics Journal;2024-03-05